
Abuja
(NAN) – The National Health Research Ethics Committee, Nigeria, has
approved the use of an experimental Ebola drug, Zmapp, for treatment of
patients infected with the virus.
The committee, which composed research scientists, is a national body under the Federal Ministry of Health.
The endorsement is contained in a statement issued to newsmen by Prof. Clement Adebamowo, Chairman of the committee on Wednesday in Abuja.
The
decision by the committee is coming on the heels of Tuesday’s approval
by the World Health Organisation (WHO) on the use of Zmapp for treatment
of Ebola patients.